CEL-SCI CORPORATION Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
CEL-SCI CORPORATION (CVM) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of -0.02% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2025-12-29
- CEL-SCI CORPORATION effective income tax rate reconciliation,other reconciling items, percent for fiscal 2025 was -0.02%.
- CEL-SCI CORPORATION effective income tax rate reconciliation,other reconciling items, percent for fiscal 2024 was -11.97%.
- CEL-SCI CORPORATION effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was -1.58%.
- CEL-SCI CORPORATION effective income tax rate reconciliation,other reconciling items, percent for fiscal 2022 was -1.67%.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month as first filed |
|---|---|---|
| 2025-09-30 | -0.02% 10-K · filed 2025-12-29 | |
| 2024-09-30 | -11.97% 10-K · filed 2025-12-29 | |
| 2023-09-30 | -1.58% 10-K · filed 2025-01-13 | |
| 2022-09-30 | -1.67% 10-K · filed 2023-12-21 | |
| 2021-09-30 | -1.37% 10-K · filed 2022-12-27 | |
| 2020-09-30 | -1.40% 10-K · filed 2021-12-21 | |
| 2019-09-30 | -28.00% 10-K · filed 2020-12-29 | -2.80% 10-K · filed 2019-12-16 |
| 2018-09-30 | -88.94% 10-K/A · filed 2019-12-23 | |
| 2017-09-30 | 0.00% 10-K · filed 2018-12-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |